Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000601736 | SCV000722715 | likely benign | not specified | 2017-09-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001406803 | SCV001608761 | likely benign | Ehlers-Danlos syndrome, type 4 | 2022-06-08 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV001406803 | SCV004818160 | likely benign | Ehlers-Danlos syndrome, type 4 | 2023-11-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004024951 | SCV005032219 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-11-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |